| 标题 |
Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Ashish Sarraju; Xiaolin Du; Luping Zhou; Luke J Laffin; Kathy Wolski; et al 出版日期:2026-08-28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)